- Home
- / Minerva Neurosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Minerva Neurosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.5
2024-10-29
Market Capitalization
$17.8 M
2024-10-29
Revenue
$41.2 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.2M | |||||||||||
| General and administrative expense | 12.0M | 7.6M | 9.8M | 10.9M | 16.8M | 17.7M | 17.3M | 13.3M | 10.6M | 10.4M | 9.9M | 9.3M |
| Operating expense total | 54.9M | 26.1M | 30.2M | 41.2M | 51.7M | 75.9M | 39.3M | 25.2M | 23.1M | 21.8M | 15.1M | |
| EBIT | (54.9M) | (26.1M) | (30.2M) | (41.2M) | (51.7M) | (75.9M) | 1.8M | (45.4M) | (25.2M) | (23.1M) | (21.8M) | (15.1M) |
| EBIT margin, % | 4.5% | |||||||||||
| Interest income | 96.9K | 198.5K | 941.8K | 1.7M | 1.5M | 161.2K | 16.5K | 556.9K | 1.4M | 1.3M | 948.1K | |
| Interest expense | 2.0M | 1.1M | 1.0M | 614.3K | 110.4K | |||||||
| Pre tax profit | (40.9M) | (50.2M) | (74.4M) | 1.9M | (51.7M) | (32.1M) | ||||||
| Income tax expense | (9.4M) | (2.3M) | (1.8M) | |||||||||
| Net Income | (56.9M) | (27.1M) | (31.0M) | (31.5M) | (50.2M) | (72.2M) | 1.9M | (49.9M) | (32.1M) | (30.0M) | 1.4M | (293.4M) |
| EPS | (6.0) | (4.6) | 0.2 | (34.7) |